Resources

Useful Resources for Psoriasis

New Zealand Resources

Medsafe Consumer Information

Download Consumer Medicine Information (PDF)

Psoriasis and Psoriatic Arthritis New Zealand Facebook

The Psoriasis and Psoriatic Arthritis NZ Facebook Group is a community for people with Psoriasis and Psoriasis Arthritis. The group welcomes new members to connect, share stories and tips and support one another.

Psoriasis and Psoriatic Arthritis New Zealand Facebook

DermNet New Zealand Trust

DermNet NZ provides authoritative information about skin diseases, conditions and treatment for patients and their health professionals.

dermnetnz.org/topics/psoriasis

Overseas Resources

Please note that treatment available in other countries may not be available in New Zealand.

National Psoriasis Foundation (USA)

Working to find a cure for Psoriasis and Psoriasis Arthritis and to eliminate their devastating effects through research, advocacy and education.

www.psoriasis.org

Talk with your doctor

Your dermatologist can answer any questions you may have and provide additional information and support.

NZ-HUM-200021. TAPS BG5630. November 2025.

This site is intended for a New Zealand audience.

Important information about HUMIRA. HUMIRA is a prescription medicine containing adalimumab. HUMIRA is available as a single use pre-filled syringe or single-use pre-filled pen and may contain 20mg, 40mg or 80mg adalimumab. It is used in the treatment of patients with rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, enthesitis-related arthritis, psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis, psoriasis, ulcerative colitis, Crohn’s disease, non-infectious uveitis, and hidradenitis suppurativa. HUMIRA is only used in patients of a specific age group, in diseases of certain severity (e.g. moderate to severe), and/or after some other treatments have been tried (e.g. conventional therapy).

HUMIRA has risks and benefits. Refer to the Safety Information contained on this website for further details. If you have any questions about using HUMIRA, ask your healthcare professional and refer to the Humira Consumer Medicine Information (CMI), the HUMIRA PEN Instructions for Use, the HUMIRA Pre-filled Syringe Instructions for Use or by calling freephone 0800 900 030. Ask your doctor if HUMIRA is right for you. Use strictly as directed. If symptoms continue, or you have side effects, see your doctor, pharmacist or healthcare professional.

HUMIRA is a fully funded medicine under Special Authority for most indications. HUMIRA is not funded for enthesitis-related arthritis, non-radiological axial spondyloarthritis and ulcerative colitis - you will need to pay for this medicine, and any doctor and pharmacy fees that apply.

AbbVie is the company that brings you HUMIRA (adalimumab). For more information about AbbVie, visit www.AbbVie.co.nz.

AbbVie Limited, Wellington 6011, New Zealand. Ph: 0800 900 030. HUMIRA and Destination You are registered trademarks of AbbVie Biotechnology Ltd.